4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001193125-26-436444
Options or other derivatives
- Chief Financial Officer acquired 27,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Silver Andrew Jacob · Chief Financial Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-26 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +18,000 | 18,000 | D |
| 2026-10-26 | Grant or award : show line 2 in the form Restricted Stock Units | +9,000 | 9,000 | D |
Loading xslF345X06/ownership.xml…